Mr. Jim Breslin:

Exactly. I know about the board meeting. In January and March, the programme board, which I chair, was only dealing with the figure of €61 million and what was being called a "backstop" around that. That backstop was intended to manage that issue without any impact on funding. The first meeting at which issues were raised was in June. The most important development at that point was the signal that the time for the GMP process would have to be extended by three months. The conversation on that topic was about pressures. The board saw that the contractors and the behaviour and interaction we were seeing were causing problems. It was taking longer, but we did not have figures at that stage. Then-----